Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Protalix BioTherapeutics (PLX) Debt Ratio (2016 - 2024)

Protalix BioTherapeutics (PLX) has 11 years of Debt Ratio data on record, last reported at 0.22 in Q2 2024.

  • For Q2 2024, Debt Ratio changed N/A year-over-year to 0.22; the TTM value through Jun 2024 reached 0.22, changed N/A, while the annual FY2023 figure was 0.24, N/A changed from the prior year.
  • Debt Ratio reached 0.22 in Q2 2024 per PLX's latest filing, down from 0.23 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.8 in Q4 2020 and bottomed at 0.04 in Q3 2021.
  • Average Debt Ratio over 4 years is 0.35, with a median of 0.24 recorded in 2023.